FDA recall D-0388-2026

ANTHONY TRINH, 123Herbals LLC · Class I · drug

Product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Distribution

USA nationwide

Key facts

Status: Ongoing
Initiation date: 2025-10-20
Report date: 2026-03-11
Voluntary/Mandated: Voluntary: Firm initiated
Location: Rosemead, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0388-2026